BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang JK, Heo S, Kim HP, Song SH, Yun H, Han SW, Kang GH, Bang D, Kim TY. Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing. PLoS One 2020;15:e0232754. [PMID: 32379795 DOI: 10.1371/journal.pone.0232754] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Chow YP, Zainul Abidin N, Kow KS, Tho LM, Wong CL. Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PLoS One 2022;17:e0276161. [PMID: 36256645 DOI: 10.1371/journal.pone.0276161] [Reference Citation Analysis]
2 Wang C, Sandhu J, Tsao A, Fakih M. Presence of Concurrent TP53 Mutations Is Necessary to Predict Poor Outcomes within the SMAD4 Mutated Subgroup of Metastatic Colorectal Cancer. Cancers (Basel) 2022;14:3644. [PMID: 35892903 DOI: 10.3390/cancers14153644] [Reference Citation Analysis]
3 He J, Xi N, Han Z, Luo W, Shen J, Wang S, Li J, Guo Z, Cheng H. The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer. Front Endocrinol 2022;13:875442. [DOI: 10.3389/fendo.2022.875442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ip A, Della Pia A, Kim GY(, Lofters J, Behrmann J, Patel D, Kats S, Estella JJ, De Dios I, Ma W, Pecora AL, Goy AH, Koprivnikar J, Mccloskey JK, Albitar M. Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms. Front Oncol 2022;12:923809. [DOI: 10.3389/fonc.2022.923809] [Reference Citation Analysis]
5 Kim S, Lim Y, Kang J, Kim H, Roh H, Kim SY, Lee D, Bang D, Jeong S, Park KJ, Han S, Kim T. Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment. Br J Cancer. [DOI: 10.1038/s41416-022-01837-z] [Reference Citation Analysis]
6 Callesen LB, Hamfjord J, Boysen AK, Pallisgaard N, Guren TK, Kure EH, Spindler KG. Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Br J Cancer 2022. [PMID: 35440666 DOI: 10.1038/s41416-022-01816-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Olmedillas-López S, Olivera-Salazar R, García-Arranz M, García-Olmo D. Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review. Mol Diagn Ther 2021. [PMID: 34773243 DOI: 10.1007/s40291-021-00562-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
8 Gong J, Hendifar A, Gangi A, Zaghiyan K, Atkins K, Nasseri Y, Murrell Z, Figueiredo JC, Salvy S, Haile R, Hitchins M. Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer. Cancers (Basel) 2021;13:4547. [PMID: 34572774 DOI: 10.3390/cancers13184547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lim Y, Kim S, Kang JK, Kim HP, Jang H, Han H, Kim H, Kim MJ, Lee KH, Ryoo SB, Park JW, Jeong SY, Park KJ, Kang GH, Han SW, Kim TY. Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR. Sci Rep 2021;11:16333. [PMID: 34381078 DOI: 10.1038/s41598-021-95345-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Koval AP, Blagodatskikh KA, Kushlinskii NE, Shcherbo DS. The Detection of Cancer Epigenetic Traces in Cell-Free DNA. Front Oncol 2021;11:662094. [PMID: 33996585 DOI: 10.3389/fonc.2021.662094] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Verbanac D, Čeri A, Hlapčić I, Shakibaei M, Brockmueller A, Krušlin B, Ljubičić N, Baršić N, Detel D, Batičić L, Rumora L, Somborac-Bačura A, Štefanović M, Ćelap I, Demirović A, Petlevski R, Petrik J, Grdić Rajković M, Hulina-Tomašković A, Rako I, Saso L, Barišić K. Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy. Int J Mol Sci 2021;22:4327. [PMID: 33919272 DOI: 10.3390/ijms22094327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ye P, Cai P, Xie J, Wei Y. The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis. PLoS One 2021;16:e0248775. [PMID: 33770081 DOI: 10.1371/journal.pone.0248775] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
13 Gao W, Chen Y, Yang J, Zhuo C, Huang S, Zhang H, Shi Y. Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer. Front Genet 2021;12:634642. [PMID: 33584829 DOI: 10.3389/fgene.2021.634642] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]